Department of Ophthalmology , University of Missouri School of Medicine , Columbia , Missouri 65212 , United States.
Department of Biochemistry , University of Missouri , Columbia , Missouri 65212 , United States.
Biochemistry. 2019 Oct 8;58(40):4148-4158. doi: 10.1021/acs.biochem.9b00374. Epub 2019 Sep 20.
The G98R mutation in αA-crystallin is associated with the onset of presenile cataract and is characterized biochemically by an increased oligomeric mass, altered chaperone function, and loss of structural stability over time. Thus, far, it is not known whether the inherent instability caused by gain-of-charge mutation could be rescued by a compensatory loss of charge mutation elsewhere on the protein. To answer this question, we investigated whether αA-G98R-mediated instability could be rescued through suppressor mutations by introducing site-specific "compensatory" mutations in αA-G98R-crystallin, αA-R21Q/G98R, αA-G98R/R116C, and αA-R157Q/G98R. The recombinant proteins were expressed, purified, characterized, and evaluated by circular dichroism (CD), intrinsic fluorescence, and bis-ANS-binding studies. Chaperone-like activities of recombinant proteins were assessed using alcohol dehydrogenase (ADH) and insulin as unfolding substrates. Far-UV CD studies revealed an increased α-helical content in αA-G98R in comparison to αA-WT, αA-R21Q, R157Q, and the double mutants, αA-R21Q/G98R, and αA-R157Q/G98R. Compared to αA-WT, αA-R21Q, and αA-G98R, the double mutants showed an increased intrinsic tryptophan fluorescence, whereas the highest hydrophobicity (bis-ANS-binding) was shown by αA-G98R. Introduction of a second mutation in αA-G98R reduced its bis-ANS-binding activity. Both αA-R21Q/G98R and αA-R157Q/G98R showed greater chaperone-like activity against ADH aggregation than αA-G98R. However, among the three G98R mutants, only αA-R21Q/G98R protected ARPE-19 cells from HO-induced cytotoxicity. These results suggest that the lost chaperone-like activity of αA-G98R-crystallin can be rescued by another targeted mutation and that substitution of αA-R21Q-crystallin at the N-terminal region can rescue a deleterious mutation in the conserved α-crystallin domain of the protein.
αA-晶体蛋白的 G98R 突变与早发性白内障的发病有关,其生化特征为寡聚体质量增加、伴侣功能改变以及随着时间的推移结构稳定性丧失。到目前为止,还不知道电荷获得突变引起的固有不稳定性是否可以通过蛋白质其他位置的补偿电荷突变来挽救。为了回答这个问题,我们通过在 αA-G98R-晶体蛋白、αA-R21Q/G98R、αA-G98R/R116C 和 αA-R157Q/G98R 中引入定点“补偿”突变,研究了 αA-G98R 介导的不稳定性是否可以通过抑制突变来挽救。重组蛋白被表达、纯化、表征,并通过圆二色性 (CD)、内源荧光和双-ANS 结合研究进行评估。使用醇脱氢酶 (ADH) 和胰岛素作为展开底物评估重组蛋白的伴侣样活性。远紫外 CD 研究表明,与 αA-WT、αA-R21Q、R157Q 和双突变体 αA-R21Q/G98R 和 αA-R157Q/G98R 相比,αA-G98R 的 α-螺旋含量增加。与 αA-WT、αA-R21Q 和 αA-G98R 相比,双突变体显示出更高的内源色氨酸荧光,而 αA-G98R 显示出最高的疏水性 (双-ANS 结合)。在 αA-G98R 中引入第二个突变降低了其双-ANS 结合活性。与 αA-G98R 相比,αA-R21Q/G98R 和 αA-R157Q/G98R 对 ADH 聚集显示出更大的伴侣样活性。然而,在这三种 G98R 突变体中,只有 αA-R21Q/G98R 能保护 ARPE-19 细胞免受 HO 诱导的细胞毒性。这些结果表明,αA-G98R-晶体蛋白丧失的伴侣样活性可以通过另一个靶向突变来挽救,并且在蛋白质的保守 α-晶体蛋白结构域中取代 αA-R21Q-晶体蛋白可以挽救有害突变。